News Release>

Signing Ceremony of Memorandum of Understanding between Tianjin Medical University Cancer Institute & Hospital and King’s College London


 The signing ceremony of a Memorandum of Understanding (MOU) between Tianjin Medical University Cancer Institute & Hospital (TMUCIH) and King’s College London (King’s) was held in Tianjin on August 23, 2019.


Observed by Mr. Richard Cowin, First Secretary of the British Embassy in China; Mr. Jianqing Zhang, Director, Department of International Exchange of Tianjin Municipal Education Commission; Prof. Chunshui Yu, Vice President of Tianjin Medical University; Mrs. Lijun Zhang, Director, Department of International Exchange & Cooperation, Tianjin Medical University and the leaders and directors of TMUCIH, Prof. Ping Wang, the president of TMUCIH and Prof. Tony Ng, Fellow of the Academy of Medical Sciences; Head of School of Cancer and Pharmaceutical Sciences, King’s College London signed the MOU between the two institutes. Both sides intend to combine forces and work together to advance cancer research and to facilitate joint education and training programs in cancer care and research.

 Prof. Bo Xu, Vice President of TMUCIH hosted the signing ceremony
Prof. Ping Wang, President of TMUCIH gave a speech at the signing ceremony
Prof. Tony Ng, Fellow of the Academy of Medical Sciences; Head of School of Cancer and Pharmaceutical Sciences, King’s College London, delivered a speech
Prof. Chunshui Yu, Vice President of Tianjin Medical University delivered a speech
Mr. Jianqing Zhang, Director, Department of International Exchange of Tianjin Municipal Education Commission, delivered a speech

Mr. Richard Cowin, First Secretary of the British Embassy in China, delivered a speech

     King's College London is one of the top 25 universities in the world and among the oldest in England. The university is research-led and based in the heart of London. King’s has a distinguished reputation in several fields including the humanities, law, social sciences and the health sciences. Its world class research is recognized through the UK’s 2014 Research Excellence Framework where eighty-four per cent of its research has been deemed world-leading or internationally excellent. Both sides have established a mechanism for promoting collaboration through leadership visits; faculty exchange; joint symposia and MDT tele-conferences in recent years. In October, 2015, The First Joint Symposium on Cancer Research between our two institutions was successfully held in Tianjin. In October, 2018, Prof. Ping Wang, President and Prof. Bo Xu, Vice President of TMUCIH led a delegation to visit King’s College London and both sides held the Second Joint Symposium.

     The signing of MOU marks an important milestone for the strategic partnership and will open a new chapter in pushing our collaborative work to a higher level. We believe that this is an excellent start for a long term cooperative effort. I clearly foresee a brighter future is unfolding for us and expect multiple benefits by our close and extensive interactions.